TP53 and cancer: The stress chaperone, mortalin (inactivation of tumor suppressor p53 and PI3K/ AKT) treated with Embelin, activates p53 by causing nuclear translocation followed by transcriptional activation and causes suppression of cancer cell growth (Nigam et al., 2015[50]; Elwakeel, 2022[19]).